D.A. Davidson & Co’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $313K | Buy |
873
+24
| +3% | +$7.34K | ﹤0.01% | 1380 |
|
|
2026
Q1 | $213K | Sell |
849
-17
| -2% | -$4.23K | ﹤0.01% | 1470 |
|
|
2025
Q4 | $238K | Sell |
866
-11
| -1% | -$3.01K | ﹤0.01% | 1397 |
|
|
2025
Q3 | $230K | Buy |
+877
| New | +$213K | ﹤0.01% | 1404 |
|
|
2025
Q1 | – | Sell |
-899
| Closed | -$294K | – | 1509 |
|
|
2024
Q4 | $294K | Sell |
899
-11
| -1% | -$3.46K | ﹤0.01% | 1210 |
|
|
2024
Q3 | $273K | Buy |
910
+2
| +0.2% | +$612 | ﹤0.01% | 1215 |
|
|
2024
Q2 | $299K | Sell |
908
-3
| -0.3% | -$1.06K | ﹤0.01% | 1165 |
|
|
2024
Q1 | $360K | Buy |
911
+9
| +1% | +$3.33K | ﹤0.01% | 1110 |
|
|
2023
Q4 | $318K | Buy |
902
+22
| +3% | +$7.79K | ﹤0.01% | 1104 |
|
|
2023
Q3 | $330K | Hold |
880
| – | – | ﹤0.01% | 1051 |
|
|
2023
Q2 | $337K | Buy |
+880
| New | +$314K | ﹤0.01% | 1060 |
|
|
2019
Q2 | – | Sell |
-4,247
| Closed | -$468K | – | 1156 |
|
|
2019
Q1 | $468K | Buy |
+4,247
| New | +$442K | 0.01% | 720 |
|
|
2017
Q3 | – | Sell |
-629
| Closed | -$59K | – | 1993 |
|
|
2017
Q2 | $59K | Buy |
+629
| New | +$57.9K | ﹤0.01% | 1479 |
|
|
2017
Q1 | – | Sell |
-533
| Closed | -$45K | – | 2510 |
|
|
2016
Q4 | $45K | Sell |
533
-11
| -2% | -$865 | ﹤0.01% | 1638 |
|
|
2016
Q3 | $40K | Hold |
544
| – | – | ﹤0.01% | 1615 |
|
|
2016
Q2 | $41K | Sell |
544
-34
| -6% | -$2.47K | ﹤0.01% | 1490 |
|
|
2016
Q1 | $40K | Sell |
578
-1,837
| -76% | -$111K | ﹤0.01% | 1476 |
|
|
2015
Q4 | $144K | Sell |
2,415
-72
| -3% | -$4.33K | ﹤0.01% | 972 |
|
|
2015
Q3 | $134K | Sell |
2,487
-295
| -11% | -$17.2K | ﹤0.01% | 979 |
|
|
2015
Q2 | $159K | Sell |
2,782
-153
| -5% | -$8.54K | 0.01% | 953 |
|
|
2015
Q1 | $175K | Sell |
2,935
-826
| -22% | -$44K | 0.01% | 916 |
|
|
2014
Q4 | $199K | Sell |
3,761
-15
| -0.4% | -$750 | 0.01% | 869 |
|
|
2014
Q3 | $168K | Sell |
3,776
-509
| -12% | -$21.6K | 0.01% | 930 |
|
|
2014
Q2 | $180K | Sell |
4,285
-138
| -3% | -$5.91K | 0.01% | 935 |
|
|
2014
Q1 | $193K | Buy |
4,423
+360
| +9% | +$16.9K | 0.01% | 893 |
|
|
2013
Q4 | $199K | Sell |
4,063
-227
| -5% | -$10.6K | 0.01% | 839 |
|
|
2013
Q3 | $176K | Sell |
4,290
-46
| -1% | -$1.75K | 0.01% | 732 |
|
|
2013
Q2 | $152K | Buy |
+4,336
| New | +$143K | 0.01% | 742 |
|
Other funds holding WST
GIM
D.A. Davidson & Co's WST Position: Q2 2026 in Review
D.A. Davidson & Co increased its West Pharmaceutical (WST) stake by 2.8% in Q2 2026, buying an estimated $7.34K and bringing the position to 873 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #1380.
D.A. Davidson & Co first reported a position in WST in Q2 2013 and has held it in 28 quarters since. The position peaked at $468K in Q1 2019. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- D.A. Davidson & Co held 873 shares of West Pharmaceutical worth $313K as of Q2 2026.
- D.A. Davidson & Co bought 24 West Pharmaceutical shares in Q2 2026, an estimated $7.34K.
- West Pharmaceutical made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #1380 holding.
- D.A. Davidson & Co first reported a position in West Pharmaceutical in Q2 2013 and has held it in 28 quarters since.
- D.A. Davidson & Co's West Pharmaceutical position peaked at $468K in Q1 2019.
- 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.